Inhibikase Therapeutics Inc (IKT)

Financing Cash Flow

-$14.49K

Quarterly · Period ending: · USD

IKT logo

IKT Financing Cash Flow

Latest reported-$14.49K
IKT Quarterly Cash from Financing (-$10.05K → -$14.49K)
High-resolution chart · PNG

IKT financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-14,489
2,897,611
108,565,322
-134,130
31,771
0
99,684,459
181,954
3,244,256
366,999
-138,104
70
-35,986
8,579,023
0
0
0
-204,769
0
29,892
41,473,441
-409,662
14,883,873
-67,132
5,309
250,120
0
0
0
-22,810
-15,439
-10,045
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.